Roche is more than doubling its total commitment to a future facility for its Genentech unit to approximately $2 billion. The plant, being built in Holly Springs, North Carolina, will be used to crank out next-generation drugs for metabolic conditions like obesity, Roche has said.
Roche scales Genentech’s North Carolina site to $2B in major obesity market play
Latest from Blog
Minnesota man captured in Somalia after allegedly helping orchestrate $250M child nutrition fraud scheme
Abdikerm Abdelahi Eidleh was captured in Mogadishu after allegedly helping orchestrate the $250 million “Feeding Our Future” fraud scheme in Minnesota. Post Views: 3
The NEPA 30, No. 7: A Nanticoke mind that taught the world how to feed the dying
The son of a coal miner in Nanticoke, Dr. Stanley Dudrick grew up witnessing the grit and survival of the Wyoming Valley. Post Views: 3
AI designs personalized burgers balancing taste, nutrition and sustainability
Stanford researcher Ellen Kuhl estimates that there are some 1043 potential burger recipes in the world. And with BurgerAI, a new tool developed in her lab, artificial intelligence can now design the
Tompkins Co. Office for the Aging launches Senior Nutrition Program Needs & Preferences Assessment, seeking public input
TOMPKINS COUNTY, N.Y. (WENY) — The Tompkins County Office for the Aging is seeking public input to help shape the future of its senior nutrition services program. A survey launched Post Views:
Panelists: New dietary guidelines could complicate health reporting
Speakers at HJ26 said the latest guidelines could potentially create confusion for consumers, health professionals and reporters. Post Views: 3